Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06886789 · ClinicalTrials.gov registry record · NA

SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation

A NA study of Cardiovascular Diseases and Cardiac Rehabilitation, sponsored by The Miriam Hospital.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT06886789: Recruiting NA study of Cardiovascular Diseases and Cardiac Rehabilitation, sponsored by The Miriam Hospital.

NCT06886789 is a NA study of Cardiovascular Diseases and Cardiac Rehabilitation that is actively recruiting participants, run by The Miriam Hospital. The registered enrollment target is 400 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06886789, a NA study of Cardiovascular Diseases and Cardiac Rehabilitation, is actively recruiting participants, sponsored by The Miriam Hospital.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

The study is sponsored by the National Heart, Lung, and Blood Institute, which is part of the National Institutes of Health. The study expects to enroll 400 subjects. The research team will recruit research participants that are finishing or will finish cardiac rehabilitation soon. Participants belong to one or more groups of people who are less often studied in cardiac rehabilitation research, may have less access to a formal cardiac rehabilitation maintenance program, or they may especially benefit from additional support after cardiac rehabilitation ends. The main purposes of this study are to evaluate which treatments work the best after cardiac rehabilitation, which order to deliver the treatments in, and which treatments are as minimally burdensome as possible while still working well. This study will make two comparisons (one comparison between a set of low-intensity interventions and another between a set of higher-intensity interventions) to determine which produces the best behavioral adherence immediately after Phase II (outpatient) cardiac rehabilitation

Primary Outcome

Weight will be measured to the nearest 0.1 kg with a digital scale in light indoor clothing without shoes. Height will be measured to the nearest millimeter with standard stadiometer procedures; those without a recent (≤3 months) clinic height measurement will be sent a paper tape measure to be taped to a wall. BMI will be calculated (kg/m2). Local participants may come to the research center. Patients will be shipped a cellular-enabled scale to be used in the same location in their home for all

Interventions

  • BEHAVIORAL Text Messaging
  • BEHAVIORAL Fully Automated Online Program
  • BEHAVIORAL Low-Intensity Cardiac Rehabilitation Maintenance Program
  • BEHAVIORAL High Intensity Cardiac Rehabilitation Maintenance Program

Study Locations (1)

Rhode Island

  • Weight Control and Diabetes Research Center of The Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2026-03-02
Est. Completion 2030-08
Phase NA
The Miriam Hospital

136 total trials

What NCT06886789 shows while recruiting

NCT06886789 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 4 interventions - of which Text Messaging is the first listed.

NCT06886789 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT06886789 about?

NCT06886789 is a clinical study titled "SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation". The study is sponsored by the National Heart, Lung, and Blood Institute, which is part of the National Institutes of Health. The study expects to enroll 400 subjects. The research team will recruit research participants that are finishing or will finish cardiac rehabilitation soon. Participants belo...

What is the current status of trial NCT06886789?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2026-03-02. Estimated completion is 2030-08.

What conditions does trial NCT06886789 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Cardiac Rehabilitation.

What interventions are being tested in trial NCT06886789?

The interventions under investigation include: Text Messaging (BEHAVIORAL), Fully Automated Online Program (BEHAVIORAL), Low-Intensity Cardiac Rehabilitation Maintenance Program (BEHAVIORAL), High Intensity Cardiac Rehabilitation Maintenance Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06886789?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06886789 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06886789's enrollment target sits among peer trials

400 106th of 300 higher than 192 of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06886789, the US trial registry maintained by the National Library of Medicine. NCT06886789 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.